We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$218B
AUM Growth
-$5.41B
Cap. Flow
-$25.1B
Cap. Flow %
-11.51%
Top 10 Hldgs %
47.1%
Holding
5,603
New
345
Increased
2,379
Reduced
1,667
Closed
541

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.82B
2
AAPL icon
Apple
AAPL
+$1.62B
3
UNH icon
UnitedHealth
UNH
+$1.03B
4
XOM icon
ExxonMobil
XOM
+$869M
5
TSLA icon
Tesla
TSLA
+$701M

Sector Composition

Rank Sector Weight
1 Technology 12.19%
2 Consumer Discretionary 5.03%
3 Healthcare 4.78%
4 Financials 4.74%
5 Communication Services 2.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REK icon
4701
ProShares Short Real Estate
REK
$11.7M
$2K ﹤0.01%
100
AEON icon
4702
AEON Biopharma
AEON
$12.9M
$1.97K ﹤0.01%
3
-283
-99% -$205K
EVLO
4703
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$1.97K ﹤0.01%
544
-588
-52% -$9.08K
TLK icon
4704
Telkom Indonesia
TLK
$14.5B
$1.96K ﹤0.01%
72
-9,318
-99% -$240K
BMTX
4705
DELISTED
BM Technologies, Inc.
BMTX
$1.84K ﹤0.01%
523
BSBR icon
4706
Santander
BSBR
$42.5B
$1.84K ﹤0.01%
346
-286
-45% -$1.55K
SBNY
4707
CALL
DELISTED
Signature Bank
SBNY
$1.79K ﹤0.01%
+9,800
New +$1.18M
BCYC
4708
Bicycle Therapeutics
BCYC
$269M
$1.79K ﹤0.01%
+84
New +$2.11K
VCEL icon
4709
Vericel Corp
VCEL
$2.35B
$1.76K ﹤0.01%
+60
New +$1.74K
MIMO
4710
DELISTED
Airspan Networks Holdings Inc
MIMO
$1.73K ﹤0.01%
2,493
-1,115
-31% -$1.38K
ZSL icon
4711
ProShares UltraShort Silver
ZSL
$65.4M
$1.63K ﹤0.01%
2
GLS
4712
DELISTED
Gelesis Holdings, Inc.
GLS
$1.61K ﹤0.01%
9,905
+5,108
+106% +$1.47K
LCID icon
4713
PUT
Lucid Motors
LCID
$2.88B
$1.61K ﹤0.01%
20
-7,980
-100% -$709K
BTBT icon
4714
Bit Digital
BTBT
$463M
$1.54K ﹤0.01%
1,000
SH icon
4715
ProShares Short S&P500
SH
$907M
$1.5K ﹤0.01%
25
GAU
4716
Galiano Gold
GAU
$455M
$1.46K ﹤0.01%
2,500
AWH
4717
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$1.43K ﹤0.01%
261
VMGAW
4718
DELISTED
VMG Consumer Acquisition Corp. Warrant
VMGAW
$1.42K ﹤0.01%
31,700
-600
-2% -$26
ALVOW icon
4719
Alvotech Warrant
ALVOW
$45.3M
$1.42K ﹤0.01%
600
SNT
4720
Senstar Technologies
SNT
$38M
$1.37K ﹤0.01%
1,000
PHI icon
4721
PLDT
PHI
$4.25B
$1.36K ﹤0.01%
54
-9
-14% -$224
VST.WS.A
4722
DELISTED
Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024)
VST.WS.A
$1.34K ﹤0.01%
12,758
IMVT icon
4723
Immunovant
IMVT
$7.93B
$1.33K ﹤0.01%
+86
New +$1.49K
TDW.WS.B
4724
DELISTED
Tidewater Inc. Series B Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.B
$1.3K ﹤0.01%
30
RTO icon
4725
Rentokil
RTO
$11.8B
$1.24K ﹤0.01%
34

Similar funds

Barclays's Q1 2023 Portfolio in Review

As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.

  • Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
  • Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
  • Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
  • Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
  • Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
  • Barclays opened 345 new positions and closed 541 in Q1 2023.
  • Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.

Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.